company? Let’s change
that.
At Elekta, our outcome-driven and cost-efficient solutions provide lasting clinical difference and are developed through sustainable environmental, social and governance practices. We’ve been working openly and proactively with clinicians and our partners for almost half a century to advance precision radiation therapy and meet continuously evolving patient needs—no matter where they are in the world. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in 120 countries and listed on Nasdaq Stockholm.
Markman Biologics has obtained a series of novel patents that pertain to Micro Resurfacing of Reconstructive tissue grafts.
Outplay, Inc. is a science-driven, biotechnology company.
DigiPath, Inc. (OTC: DIGP) has over 60 years combined expertise in pioneering digital pathology
CLS focuses on the extraction and conversion of cannabinoids in the United States.
Bio Adaptives provides natural stem cell therapy solutions to create scientifically valid, research-based natural wellness solutions.
Since our founding in 2003, NMT has made remarkable progress in bringing to market a comprehensive suite of innovative noninvasive
An innovative healthcare venture capital firm. Genetics, pharma and wider biotech. America & Asia HQ. Founded in 2010.
Work Your Passion. Live Your Purpose.